Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
7(41%)
Results Posted
50%(1 trials)

Phase Distribution

Ph not_applicable
6
35%
Ph phase_2
1
6%
Ph phase_4
7
41%

Phase Distribution

0

Early Stage

1

Mid Stage

7

Late Stage

Phase Distribution14 total trials
Phase 2Efficacy & side effects
1(7.1%)
Phase 4Post-market surveillance
7(50.0%)
N/ANon-phased studies
6(42.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

7

trials recruiting

Total Trials

17

all time

Status Distribution
Active(11)
Completed(2)
Other(4)

Detailed Status

Recruiting6
unknown4
Not yet recruiting4
Completed2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
7
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (7.1%)
Phase 47 (50.0%)
N/A6 (42.9%)

Trials by Status

unknown424%
completed212%
active_not_recruiting16%
recruiting635%
not_yet_recruiting424%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT03753555Phase 4

The Effect of InTensive Statin in Ischemic Stroke With inTracranial Atherosclerotic Plaques

Recruiting
NCT05397405Not Applicable

Improving Blood Lipid Management in Symptomatic Intracranial Atherosclerotic Stenosis on Clinical Outcome

Recruiting
NCT07174375Phase 2

PCSK9 Inhibitors in Acute Ischemic Stroke Patients Undergoing Endovascular Therapy

Not Yet Recruiting
NCT07084259Phase 4

Single Dose PCSK9 Inhibitor to Improve Cardiovascular Outcomes After PCI: A Pilot Study

Not Yet Recruiting
NCT06649240Not Applicable

Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke

Recruiting
NCT06738758

Multicenter Real-World Cohort Study Evaluating the Impact of Early Intensive Lipid-Lowering Therapy on the Prognosis of Acute Coronary Syndrome Patients(ELITE-ACS)

Recruiting
NCT06854523Not Applicable

Assessing Coronary Non-Culprit Plaque Early with Start of PCSK9 Inhibitors in Acute Myocardial Infarction (ACCESS-AMI)

Not Yet Recruiting
NCT05537948Phase 4

Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant Patients

Active Not Recruiting
NCT06730802Not Applicable

Protective Effect of PCSK9 Inhibitor Against Negative Inflammatory Response and Organ Dysfunction After Coronary Artery Bypass Grafting (PANDA VIII)

Not Yet Recruiting
NCT04369664Phase 4

CHOlesterol Lowering and Residual Risk in Type 2 Diabetes

Completed
NCT06520904Phase 4

Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography

Recruiting
NCT04847752

Study of Predictive Factors Related to Prognosis of Patients With Ischemic Stroke Due to Large-artery Atherosclerosis

Recruiting
NCT05623995Phase 4

Effect of Evolocumab on Chronic Total Occlusions (EVOLO-CTO)

Unknown
NCT06034691Not Applicable

Exploratory Research of PCSK9 Inhibitor on Patency of aAVF After PTA With PCB

Unknown
NCT04319081

Study to Evaluate Changes in Cognitive Function in Patients Treated With PCSK9 Inhibitors

Completed
NCT04730648Not Applicable

Acute Myocardial Infarction and Unstable Angina Patients With PCSK9 Inhibitor Usage Study

Unknown
NCT05298475Phase 4

Low-dose PCSK9 Inhibitor Combined With Stains on Serum Lipids in Chinese Population With Acute Coronary Syndrome

Unknown

All 17 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
17